Motapizone (NAT 05-239) is a selective PDE3 inhibitor that suppresses cytokine release in LPS-induced human alveolar macrophages, increases intracellular cAMP, and inhibits human platelet aggregation.
Molecular Weight:
260.32
Purity:
95.26%
CAS Number:
[90697-57-7]
Formula:
C12H12N4OS
Target:
cAMP|||Others|||PDE|||Platelet aggregation
T73667
T73667
* VAT and and shipping costs not included. Errors and price changes excepted
